Abstract: Venomous mammals are rare, and only a few species in the orders Insectivora and Monotremata produce toxic venom. Among them, the duckbill platypus (Ornithorhynchus anatinus) is one of the two venomous Australian mammals. The adult male platypus carries a spur on each hind leg, which it uses to inject competitors with poison. However, the structure and function of the poison's active compounds are still imcompletely characterized. We found that crude platypus venom produced potent Ca 2+ influx in human neuroblastoma IMR-32 cells. Guided by this assay, we identified 11 unique peptides, including peptide H-His-Asp-His-Pro-Asn-Pro-Arg-OH, which coincided with the N-terminal domain residues of Ornithorhynchus venom C-type natriuretic peptide (OvCNP). This heptapeptide induced a significant increase in [Ca 2+ ] i in IMR-32 cells at 75 μM; had relatively specific affinities for glutamate, histamine, and GABA A receptors; and facilitated neurogenic twitching in guinea pig ileum specimens at 30 μM. We also established that its proteinous venom fraction strongly hydrolyzed Pro-Phe-Arg-MCA and cleaved a human low-molecularweight kininogen (LK), similar to porcine pancreas kallikrein. These results strongly indicated that platypus venom contains tissue kallikrein-like protease(s), and its proteolytic activity might synergistically contribute to toxicity through the specific cleavage of other venom constituents.
INTRODUCTION
Many toxic constituents from lower animals, such as insects, lizards, and snakes, have been well characterized. However, venomous mammals are quite rare, and only a few species, such as shrews and the solenodon (Insectivora), as well as the duckbill platypus (Monotremata), are known to produce toxic venom [1] . Since the disappearance of dinosaurs (~65 million years ago), these venomous mammals are believed to have evolved with little change in morphology. Interestingly, among living mammals, only these most ancient species produce toxic venom. Thus, identification of the unique bioactive substances in mammalian venoms should help to clarify their evolutional properties and ecological roles. Owing to their instability as well as the difficulty of collecting fresh venom fluid or venomous gland specimens in sufficiently large amounts, mammalian venoms have not been well characterized. However, now that the recent advancements in spectroscopic analyses and genetic approaches are available, we have sought to isolate scarce, unstable, and composite toxic substances of mammalian origin.
Shrews have both the smallest size and the highest metabolic rates among mammals. Venomous shrews are known to not only eat worms and insects, but also to attack vertebrates, even larger than themselves [2] . For example, the short-tailed shrew Blarina brevicauda feeds on murid rodents and frogs [3] [4] [5] . The semi-aquatic shrew Neomys fodiens feeds on frogs, newts, and small fish. Therefore, these shrew species may use venom to effectively catch and immobilize large prey to meet their own high metabolic demands [6, 7] . We previously identified blarina toxin (BLTX), lethal venom with a tissue kallikrein-like activity, from the salivary glands of B. brevicauda. Mice that were administered BLTX i.p. developed irregular respiration, paralysis, and convulsions before dying [8] [9] [10] . Homology modeling studies of BLTX revealed that most of the amino acid residues in BLTX highly overlapped those of human tissue kallikrein, including presumed catalytic site residues [11, 12] .
Meanwhile, the duckbill platypus, Ornithorhynchus anatinus, is one of the two venomous Australian mammals (Fig. 1) [13] . The adult male platypus carries a spur on each hind leg, which it uses to inject competitors with poison. Envenoming by a platypus causes immediate, excruciating pain in humans, which evolves toward a long-lasting hyperalgesia (hypersensitivity to pain). Since the end of the 19 th century, several constituents of the platypus venom fluid or its crural gland have been identified [14] [15] [16] . Recently, several Australian chemists and biologists have made special efforts to identify and characterize the unique venom constituents [17] [18] [19] . They include defensin-like peptides [20] [21] [22] [23] , C-type natriuretic peptides (OvCNPs) [24] [25] [26] , nerve growth factor (NGF), and hyaluronidase. In addition, an L-to-D-peptide isomerase has been identified, by which D-Leu 2 in OvCNPs and D-Met 2 in defensins are formed [27] [28] [29] [30] . While this platypus peptide isomerase was the first identified one of mammalian origin, it was recently shown that this enzyme is also contained in mouse heart and echidna venom [31, 32] . However, the specific neurotoxic substances in platypus venom that lead to excruciating pain are still incompletely characterized.
In 2008, the platypus genome project was completed. It revealed that the platypus genome consists of 18 500 protein-coding genes, and shows reptilian, avian, and mammalian features [33, 34] . Various "blueprints of life" have been unveiled in animals ranging from insects to humans. However, to clarify complex and dynamic living systems, it is essential that we investigate the structures and functions of the true bioactive molecules in venom systems.
As mentioned in the previous reviews, we have focused on the identification of natural key compounds that control biologically and physiologically intriguing phenomena [35] [36] [37] [38] [39] . Recently, we had the opportunity to obtain fresh platypus venom, with the kind cooperation of Taronga Zoo, Sydney, Australia, and identified picomole amounts of several unique peptides in this venom fluid [40] . This review discusses the identification, biological activities, and biosynthesis of these peptides, as well as an investigation of the proteinous components in platypus venom.
RESULTS AND DISCUSSION

Identification and structures of peptides in platypus venom
With fresh platypus venom fluid in hand, various bioassays were carried out. Intravenous or intracerebral administration in mice did not produce any significant symptoms, and no hemolytic activity was observed against rabbit or sheep red blood cells. However, the venom produced potent Ca 2+ influx in human neuroblastoma IMR-32 cells [11] . Notably, unlike the rapid temporary increase in [Ca 2+ ] i (internal calcium ion) caused by KCl, the calcium uptake caused by 1 was slow and continuous. Thus, we anticipated that platypus venom might contain some physiologically important neurotoxic substances.
Since platypus venom contains molecules of various sizes, we first chose gel-permeation high-performance liquid chromatography (HPLC) for purification, and the lower-molecular-weight components, fraction IX (discussed below), showed Ca 2+ influx activity. Further purification by reverse phase HPLC gave peptide 1 as a primary component (~200 ng/μL venom fluid) ( Fig. 2 ) [41] . Through the use of matrix-assisted laser desorption/ionization with time-of-flight mass spectrometry (MALDI-TOF/TOF MS) analysis, the primary structure of 1 was established to be H-His-Asp-His-Pro-Asn-Pro-Arg-OH, which coincided with the N-terminal domain residues of platypus CNP [40] . CNPs are vasorelaxant peptide hormones that are widely expressed in vivo, including the central nervous system [42] . OvCNPs cause the relaxation of rat uterine smooth muscle, promote histamine release from mast cells, and form fast cation channels in lipid bilayers [24, [43] [44] [45] . This is the first example of the isolation of N-terminal domain residues of CNPs in any mammal.
Furthermore, direct HPLC purification of crude platypus venom afforded peptides 3 and 4 as major constituents [46] . By comparing the retention times of synthetic and natural peptides, we confirmed that the Leu 2 residues in both peptides were of the D-form. Furthermore, a hexapeptide 2, peptides 5-8, and peptides 9-11 were purified from the fr. VI as major constituents. Peptides 2-4 were analogs of 1, which coincided with the 6-9 N-terminal domain residues of OvCNP. Meanwhile, peptides 5-9 corresponded to the 132-150 part of OvCNP precursor peptide (pre-OvCNP). The y-ion fragment patterns in MS/MS data suggested that the 12 C-terminal residues in peptides 10 and 11 were identical to those in 9, but their molecular mass units were 17 less and 1 more than those of pre-OvCNP (132-150), respectively. Further detailed MS/MS analysis revealed that 10 had a cyclic amide structure at the N-terminal Ala 1 -Asn 2 moiety by deamidation (Fig. 3 ) [47] , while the amide moiety of the Asn 2 residue was hydrolyzed to an Asp residue in 11.
Biological activities of peptides in platypus venom
Synthetic heptapeptide 1 showed significant Ca 2+ influx activity in IMR-32 cells at 75 μM [40] . Unlike the fast and temporary increase in [Ca 2+ ] i caused by KCl, the calcium uptake caused by 1 was slow and continuous, which was identical to the result with crude venom. In addition, among peptides 1-9, only heptapeptide 1 produced prominent inflammation (s.c. injection, 1 mg per 10 g mice) and shaking behavior (intracerebral injection, idem) [48, 49] .
We used differentiated IMR-32 cells that expressed L-and N-type voltage-gated calcium channels (VGCCs). Based on the results of various receptor-binding assays, however, heptapeptide 1 did not significantly bind to L-or N-type VGCCs, potassium channels (K A and K ATP , hERG), or a sodium channel (site 2) at 10 μM (Table 1) . These results suggested that the venom peptide 1 may not directly activate known voltage-gated ion channels, but may specifically bind to other receptor channels or biomacromolecules. Indeed, among the various receptors tested that are related to pain, inflammation, or neurotransmission, 1 had relatively specific affinities for glutamate, histamine H 1 , and GABA A receptors. Next, we compared the receptor antagonism activities of 1 and its analogs 3, 4, and 4' (an L-Leu 2 analog of 4) for the selected receptors described above (Fig. 4) . Among glutamate receptors, while natural peptides 1, 3, and 4 all bound similarly to kainate-type receptors, different affinities were observed for NMDA-type. It is interesting how these binding specificities can be linked to the neurotoxicity of 1 or kainic acid in mice. Furthermore, heptapeptide 1 facilitated a neurogenic twitching in guinea pig ileum specimens at 30 μM. Thus, compound 1 was found to have agonist activity at histamine H 1 or GABA A receptors, which might be related to its inflammatory activity in mice.
Protease activity and SDS-PAGE analysis of platypus venom
Since the C-termini of several platypus venom peptides, 1, 2, and 4-8, were free arginine residues (Fig. 2) , we anticipated that platypus venom had trypsin or kallikrein-like protease activity. Indeed, a proteinous venom fraction, especially fr. II, strongly hydrolyzed Pro-Phe-Arg-MCA, a fluorescent peptide substrate of tissue kallikrein (Fig. 5a ).
We also examined the in vitro kininogen cleavage activities of platypus venom. On sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) analysis, fr. II degraded a human lowmolecular-weight kininogen (LK) in a time-dependent manner (Fig. 6a) . The degradation products resulting from incubation with fr. II appeared to be identical to those obtained by incubation with porcine pancreatic kallikrein (PPK). Furthermore, these degradations were markedly suppressed by the serine protease inhibitor aprotinin (bovine pancreatic trypsin inhibitor). These observations strongly indicated that platypus venom contains tissue kallikrein-like protease(s).
Tissue kallikrein (EC 3.4.21.35) cleaves diverse polypeptide precursors such as kininogens, epidermal growth factor, NGF, and angiotensinogen, and also liberates biologically active peptides in vitro [50] . This enzyme is uniquely characterized by its ability to hydrolyze two specific and distinct peptide bonds, Met-Lys (human) or Lys-Arg (mouse), and Arg-Ser (all mammals), within kininogens to release lysyl-bradykinin (kallidin) or bradykinin (BK), respectively (Fig. 6b) . Liberated kinins potently relax vascular smooth muscle, increase vasodilation, and enhance vascular permeability [51, 52] . Thus, it has been suggested that the kallikrein-kinin system may play an important role in blood pressure homeostasis and pain. It was found that the lethal venom of Blarina shrew, BLTX, converts kininogens to kinins. Furthermore, both the acute toxicity in mice and proteolytic activity of BLTX are strongly inhibited by aprotinin, which suggests that its toxicity is due to a kallikrein-like activity of the venom [8, 9] . Several kallikrein-related proteases, including gila toxin (GTX) and horridum toxin (HTX), have been isolated as lethal factors from lizards [53, 54] . Both of these toxins have hypotensive effects when injected into rats, and are also hemorrhagic, yet only HTX causes exophthalmia (protrusion of the eyes) [55] . While platypus venom is not lethal in mice, it is interesting that all of these venomous vertebrates produce and use such similar secretory serine proteases.
In an SDS-PAGE analysis of the higher-molecular-weight components of platypus venom, several proteins were detected between fr. II-IV (Fig. 5b) . It was established that by the detailed MS/MS analysis of the tryptic peptide fragments obtained by an in-gel digestion, two major proteins in fr. III were α-trypsin inhibitor (α 1 TI, 51 kDa) and lactoferrin (80 kDa), respectively [56] . Meanwhile, kallikrein-like protease(s) were present in very minute amounts, and have not yet been identified, but might correspond to a single 48-kDa band of the first half of fr. II.
A cDNA library from its venom gland was constructed by the researchers who decoded the platypus genome [57] . Based on its transcriptome data, 83 putative platypus venom peptides/proteins in 13 different families were identified, and interestingly, the largest group consisted of serine proteases. Most recently, gene duplications and the expression of transcripts were analyzed in an in-season platypus venom gland, which included several serine proteases, metalloproteinases, and protease inhibitors [58] . It was noteworthy that serine proteases (kallikrein and other) and Kunitz-type protease inhibitors (α 1 TI), which are likely to produce symptoms associated with envenomation such as vasodilation and pain, were found to be contained in platypus venom based on both gene expression and secreted mature protein levels.
Biosynthesis of peptides in platypus venom
While the real targets of platypus kallikrein are still unknown, we expected that its proteolytic activity might synergistically contribute to toxicity through the specific cleavage of other venom constituents. Figure 7 summarizes a proposed biosynthesis of venom peptides. It is reasonable that OvCNP-39a is formed from a precursor, pre-OvCNP (208 amino acids), and that the Leu 2 residue is partially isomerized into the D-form to give 39b [27] . Meanwhile, the N-terminal domain CNP fragment peptides 1, 3, and 4 may be formed by the specific degradation by kallikrein-like protease(s) and dipeptidyl peptidases. cold 0.1 M NH 4 OAc, loaded on a TSKgel G2000SW XL column (7.8 mm I.D. × 300 mm, TOSOH Co., Osaka, Japan), and eluted with 0.1 M NH 4 OAc at a flow rate of 0.2 mL/min, with monitoring at 280 nm at 4 °C. Twenty fractions were collected from 20 to 120 min, and every two fractions were combined to give 10 fractions, fr. I-X (Fig. 5a ). 2/5 amounts of each fr. I-X were freeze-dried, dissolved in water (100 μL), and freeze-dried again. This step was repeated twice to remove the remaining ammonium acetate. The lyophilized samples were subjected to cell-based Ca 2+ influx assays and SDS-PAGE analysis (Fig. 5b) .
2/5 amounts of fr. IX were loaded on a C 30 Develosil RP-AQEUOUS AR-5 semi-micro column (1.5 mm I.D. × 150 mm, Nomura Chemical Co., Aichi, Japan) at 20 °C. A linear gradient of 0-25 % aq. MeCN for 120 min containing 0.05 % TFA was applied at a flow rate of 100 μL/min to give heptapeptide 1 (~400 ng). Similarly, 1/20 amount of fr. VI was separated to give hexapeptide 2 (~20 ng), a mixture of peptides 5-8 (total ~40 ng), and a mixture of peptides 9-11 (total ~30 ng), respectively. Furthermore, 1 μL of the platypus venom fluid (corrected in the breeding season) was separated to give heptapeptide 3 (~200 ng) and nonapeptide 4 (~50 ng), respectively.
Enzyme assay
Enzyme activity using the Pro-Phe-Arg-MCA substrate was analyzed with a Hitachi F-4500 fluorescence spectrophotometer by measuring the amount of 4-amino-7-methyl-coumarin (AMC) released, with excitation and emission wavelengths of 370 nm and 460 nm, respectively, at 37 °C, as previously described [8] . One unit was defined as 1 μmol of AMC released from peptidyl-MCA substrates per minute, at 37 °C.
The degradation of kininogens was measured by incubating 0.2 mg/mL LK in 50 mM TrisؒHCl buffer (pH 8.5) with platypus venom fr. II (3.3 μL, 2 mU) or PPK (14 ng, 2 mU) at 37 °C, with a reaction mixture volume of 20 μL. At 0, 10, 30, and 60 min, 5 μL of the reaction mixture was withdrawn and added to 5 μL of denaturing solution, as previously described [8, 9] . After the samples were boiled for 5 min, SDS-PAGE was performed using a precast 10 % polyacrylamide gel (ATTO Co., Tokyo, Japan), and the gels were stained with a Silver Stain Kit, Protein (Amersham). To determine the inhibition of enzymatic activity by a protease inhibitor, the platypus venom fr. II or PPK (0.5 mU each) was incubated with 10 μM aprotinin for 5 min at 37 °C before use.
